Clinical Trial Update: A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma [Phase 3]

View source ↗

Summary

A randomized Phase III trial compares R-mini-CHOP with R-mini-CHP plus polatuzumab vedotin in diffuse large B-cell lymphoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: Nordic Lymphoma Group | Conditions: DLBCL, Diffuse Large B Cell Lymphoma | Phase 3 | Status: RECRUITING